-
Nouscom Appoints Seasoned Executive Eckhard Niemeier as Chief Business Officer
03 Dec 2024 08:00 GMT
… the-shelf and personalized neoantigen cancer immunotherapies, announces the appointment of … and completed his thesis at Human Genome Sciences. Mr. Eckhard Niemeier, CBO, … the-shelf and personalized neoantigen cancer immunotherapies, along with its innovative …
-
CAR T Therapy: From Cancer To Autoimmune Disease, The Lupus Example
01 Nov 2022 17:11 GMT
… as applications for B cell cancers and multiple myeloma can be … CAR T therapy as a cancer treatment. A recent study published … . One of our successes at Human Genome Sciences, a company I founded and …
-
Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi
23 Sep 2024 11:00 GMT
… with a variety of cancers, today announced the appointment … helped accelerate corporate growth at Human Genome Sciences, Genzyme, and Amgen. “ … for the treatment of cancer. By combining our expertise … and platinum-resistant ovarian cancer reading out in the …
-
ADvantage Therapeutics, Inc. Welcomes Dr. William A. Haseltine as Strategic Advisor to Drive Innovation in Alzheimer's Disease Research and Anti-aging Therapies such as Klotho Protein Supplementation to Extend Healthy Human Lifespan
09 Sep 2024 14:01 GMT
… to the fields of virology, cancer research, and biotechnology. As … several successful biotech companies, including Human Genome Sciences, Dr. Haseltine has been instrumental … , chronic kidney disease, and cancer increases. ADvantage Therapeutics is pioneering …
About
© 1995-2025